The following is a post from Center for Global Health Policy Officer Carol Bergman, who recently traveled to Kenya with a group of Capitol Hill staff from key Congressional offices with jurisdiction over global health funding or programs. The purpose of our trip to Kenya was to better understand the impact of how US dollars […]
The second in a series of interviews with staff members of the Office of the U.S. Global AIDS Coordinator (OGAC), responsible for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program, Science Speaks sat down with Winnie Roberts, PhD. As director of multilateral diplomacy, Roberts manages OGAC’s engagement with the Global Fund to Fight […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of […]